Showing results (1141-1150 of 10,077) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|July 30, 2013
DNA demethylation: where genetics meets epigeneticsXiaofei Zhang, Rongguo Fu, Jie Yu, et al.Current Pharmaceutical Design|July 30, 2013
Transcription factor WT1 and promoter CpG hypomethylation coactivate HOXA10 expression in ovarian cancerYi Jiang, Yongli Chu, Weiwei Tang, et al.Current Pharmaceutical Design|July 30, 2013
Development of an intracellular, DNA methyltransferase-specific, and gene-specific assay for studying dynamic DNA methylationJesus Gonzalez-Bosquet, Yongli Chu, Hai Bin Chen, et al.Current Pharmaceutical Design|July 30, 2013
Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancerAmanda S Bruegl, Bojana Djordjevic, Diana L Urbauer, et al.Current Pharmaceutical Design|July 30, 2013
Decreased expression and altered methylation of syncytin-1 gene in human placentas associated with preeclampsiaXue-Wei Zhuang, Jinping Li, Brian C Brost, et al.Current Pharmaceutical Design|July 30, 2013
De novo DNMTs and DNA methylation: novel insights into disease pathogenesis and therapy from epigenomicsSylwia Leppert, Maria R MatarazzoCurrent Pharmaceutical Design|July 30, 2013
The "Methyl-CpG Binding Domain protein 2" plays a repressive role in relation to the promoter CpG content in the normal human cell line MRC5Laury Perriaud, Joel Lachuer, Robert DanteCurrent Pharmaceutical Design|July 30, 2013
HDAC as a therapeutic target for treatment of endometrial cancersJuan Ren, Jia Zhang, Hui Cai, et al.Current Pharmaceutical Design|July 30, 2013
Expression of histone acetyltransferase GCN5 and histone deacetylase 1 in the cultured mouse preimplantation embryosXiaozhen Liu, Dongmei Zhao, Yingming Zheng, et al.Current Pharmaceutical Design|July 30, 2013
Histone modifications, stem cells and prostate cancerFrancesco Crea, Pier-Luc Clermont, Antonello Mai, et al.Pageof 1,008